News
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...
GSK (GSK.L), opens new tab has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer ...
WJET Erie on MSN8mon
Drugmaker to settle nearly 80,000 Zantac lawsuits for up to $2.2 billionor GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level Zantac cases. The lawsuits claimed ...
GSK has reached agreements with 10 plaintiff firms to settle around 80,000 state court product liability cases related to its heartburn medication, Zantac ... GSK agreed to pay $70 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback